From the Architecture et Fonction des
Macromolécules Biologiques, UMR 6098 CNRS et Université
Aix-Marseille I et II, ESIL, Campus de Luminy, 13288 Marseille Cedex
09, France, ** MRC Virology Unit, Institute of Virology,
Church St., Glasgow G11 5JR, United Kingdom, and
European Synchrotron Radiation Facility, BP
220, 38043 Grenoble Cedex, France
Received for publication, January 16, 2003, and in revised form, March 3, 2003
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The nucleoprotein of measles virus
consists of an N-terminal moiety, NCORE, resistant to
proteolysis and a C-terminal moiety, NTAIL, hypersensitive
to proteolysis and not visible as a distinct domain by electron
microscopy. We report the bacterial expression, purification, and
characterization of measles virus NTAIL. Using nuclear
magnetic resonance, circular dichroism, gel filtration, dynamic light
scattering, and small angle x-ray scattering, we show that
NTAIL is not structured in solution. Its sequence and spectroscopic and hydrodynamic properties indicate that
NTAIL belongs to the premolten globule subfamily within the
class of intrinsically disordered proteins. The same epitopes are
exposed in NTAIL and within the nucleoprotein, which rules
out dramatic conformational changes in the isolated NTAIL
domain compared with the full-length nucleoprotein. Most unstructured
proteins undergo some degree of folding upon binding to their partners,
a process termed "induced folding." We show that NTAIL
is able to bind its physiological partner, the phosphoprotein, and that
it undergoes such an unstructured-to-structured transition upon binding
to the C-terminal moiety of the phosphoprotein. The presence of
flexible regions at the surface of the viral nucleocapsid would enable plastic interactions with several partners, whereas the gain of structure arising from induced folding would lead to modulation of
these interactions. These results contribute to the study of the
emerging field of natively unfolded proteins.
Measles virus (MV)1 is an enveloped RNA virus within
the Morbillivirus genus of
the Paramyxoviridae family. Its nonsegmented, negative
sense, single-stranded RNA genome is packaged by the viral
nucleoprotein (N) within a helical nucleocapsid. Transcription and
replication are carried out on this (N·RNA) complex by the RNA-dependent RNA polymerase polymerase (L) associated with
the phosphoprotein (P) (reviewed in Refs. 1 and 2). During genome replication, synthesis of viral RNA and encapsidation by N are concomitant (1, 2). However, N has the capacity to self-assemble on
cellular RNA to form nucleocapsid-like particles in the absence of
viral RNA and of any other viral protein (3-7). Therefore, a
regulatory mechanism is necessary to prevent illegitimate self-assembly of N onto cellular RNA in the absence of ongoing genomic RNA synthesis. This role is played by P; association of P with the soluble, monomeric form of N (N°) prevents its illegitimate self-assembly (8-10). This
soluble N°·P complex is the substrate used by the polymerase to
initiate encapsidation of genomic RNA (10, 11). N forms complexes with
P and with the P·L complex during transcription and replication also
in its self-assembled form (NNUC) (12-15).
Deletion analyses have shown that nucleoproteins of
Paramyxoviridae are divided into two regions: a N-terminal
moiety, NCORE, well conserved in sequence, and a
hypervariable, C-terminal moiety, NTAIL (2) (see Fig.
1A). NCORE contains all of the regions necessary
for self-assembly and RNA binding (16, 17). Within NCORE,
deletion and mutational studies have shown that the central conserved
region (MV; aa 258-357) and the aa 189-239 region, are involved in
self-association and in RNA binding (4, 18-21). The precise location
of RNA binding sites within NCORE is unknown. The RNA
binding site is probably formed by maturation of N during encapsidation, as suggested by the observation that all N mutants displaying an impaired self-association are not able to package RNA (4,
19, 21).
Within nucleocapsids, NTAIL protrudes from the globular
body of NCORE (22, 23). In Morbilliviruses and
Respiroviruses, the region responsible for binding of
nucleocapsids to P is located within NTAIL (13, 18, 20,
24). Consequently, NTAIL is required for N·RNA to act as
a template for viral RNA synthesis (13, 16, 25). NTAIL has
also been shown to be required for stable binding of N° to P (16,
26).
Besides its role in encapsidating viral RNA, N also plays a role during
viral assembly by interacting with the matrix protein (M) (27). The
M-binding region of nucleocapsids has recently been mapped to
NTAIL in Respiroviruses (27), in agreement with the accessibility of NTAIL on the surface of the
nucleocapsid and with its net negative charge, which would favor the
interaction with the highly positively charged M protein.
The fact that NTAIL is not readily visualized by electron
microscopy (EM) (28) and is hypersensitive to proteolysis (4, 28)
strongly suggests that it is mostly unstructured within nucleocapsids,
at least after isolation (29).
During the last decade, it has been shown that a considerable number of
proteins (>100) have little or no ordered rigid structure under
physiological conditions. These proteins are referred to as natively
unfolded or "intrinsically disordered or unstructured" (for
reviews, see Refs. 30-32). Conformational analysis has shown that
natively unfolded proteins do not represent a uniform family, but
rather they can be subdivided into two structurally distinct groups.
The first group consists of proteins with extended hydrodynamic dimensions typical of random coils with no (or little) ordered secondary structure. The second group comprises the so-called premolten
globules, which are more compact (but still less compact than globular
or molten globule proteins) and conserve some residual ordered
secondary structure (31, 32).
It has recently been proposed that the protein structure-function
paradigm should be better replaced by the "protein quartet model"
(31). According to this model, proteins can exist in any of the four
thermodynamic states of proteins (ordered, molten globule, premolten
globule, and random coil), and function can arise from any of these
conformations and transitions between them. The functional importance
of disorder may reside in advantages of flexible structures in
comparison with rigid structures. In particular, an increased
plasticity would (i) allow to couple a high specificity with a low
affinity, (ii) enable binding of numerous structurally distinct
targets, and (iii) provide the ability to overcome steric restrictions,
enabling larger interaction surfaces in protein-protein and
protein-ligand complexes than those obtained with rigid partners
(31-35).
In this paper, we report the bacterial expression, purification, and
characterization of MV NTAIL. Using different,
complementary biochemical and biophysical methods, we show that
NTAIL is intrinsically disordered and belongs to the
premolten globule subfamily. We also show that NTAIL is
able to bind its physiological partner, P. Although there are
intrinsically disordered proteins that carry out their function while
being disordered from end to end (32), a majority folds in the presence
of their physiological partner(s) (36, 37), a process known as
"induced folding." We show that NTAIL undergoes such an
unstructured-to-structured transition upon binding to the C-terminal
moiety of P (PCT).
Bacterial Strains and Media--
The Escherichia coli
strain XL1 Blue (Stratagene) was used for selection and amplification
of DNA constructs. The E. coli strains BL21[DE3] and BL21
(Novagen) were used for expression of recombinant proteins. E. coli was grown in Luria-Bertani medium.
Chemicals and Antibodies--
Restriction enzymes and T4 DNA
ligase were purchased from NE Biolabs. Pfu polymerase was
from Promega. Primers were purchased from Genosys. Nucleotide
sequencing was carried out by Genome Express. The anti-hexahistidine
tag monoclonal antibody (mAb) was purchased from Qiagen. The anti-N Cl
105 2 and Cl 25 (38, 39) and
the anti-P 49.21 mAbs (40) were kindly provided by D. Gerlier.
Plasmids--
The plasmid pQE32/NTAIL, encoding
residues 400-525 of MV N (strain Edmonston B) with a hexahistidine tag
fused to its N terminus was a kind gift of C. Rabourdin-Combe.
The plasmids pET21a/PH6 and pET21a/P encoding the MV P
protein (strain Edmonston B) with or without an N-terminal
hexahistidine tag, respectively, have been already described (41). The
PCT gene construct, encoding the C-terminal moiety of P (PCT) (residues 231-507 of P) with a hexahistidine tag fused to its N terminus, was
obtained by PCR, using pET21/PH6 as template. Forward
primer (5'-GGCCCATATGCACCATCATCATCATCATGGCACAGACGCGAGATTAGCCTCAT-3') was designed to introduce an NdeI restriction site fused to
the N terminus of PCT, whereas reverse primer
(5'-CCGGGAATTCTTACTTCATTATTATCTTCAT-3') was designed to
introduce an EcoRI site after the P stop codon. The PCR
product was digested with NdeI and EcoRI,
purified, and ligated between the NdeI and EcoRI
sites of pET21a to yield pET21a/PCTH6.
The plasmid pET21a/PNTH6, encoding the N-terminal domain of
P (PNT) (residues 1-230 of P) with an N-terminal hexahistidine tag,
has been already described (41).
The plasmid pET21a/NFLAG-H6, which encodes MV N with an
N-terminal FLAG sequence (DYKDDDDK) (42) and a C-terminal hexahistidine tag, has already been described (4).
Expression of NTAIL and PCT--
E. coli
strains BL21 and BL21[DE3] were used for the expression of
pQE32/NTAIL and of pET21a-derivative constructs,
respectively. Since MV N and P genes contain several rare arginine
codons (AGG) that are used with a very low frequency in E. coli, co-expression of N and P constructs with the plasmid pUBS520
(43), which supplies the corresponding rare tRNA, was carried out.
Cultures were grown overnight to saturation in Luria-Bertani (LB)
medium containing 100 µg/ml ampicillin and 50 µg/ml kanamycin. An
aliquot of the overnight culture was diluted 1:25 in LB medium and
grown at 37 °C. At A600 of 0.7, isopropyl
Expression of tagged N, PNT, and untagged P was carried out as
described in Refs. 25 and 48.
Purification of NTAIL and PCT--
The pellet
containing NTAIL was resuspended in 5 volumes (v/w) buffer
A (50 mM sodium phosphate, pH 8, 300 mM NaCl,
10 mM imidazole, 1 mM phenylmethylsulfonyl
fluoride (PMSF)) supplemented with 0.1 mg/ml lysozyme, 10 µg/ml DNase
I, and protease inhibitor mixture (Sigma) (50 µl/g of cells). After a
20-min incubation with gentle agitation, the cells were disrupted by
sonication (using a 750-watt sonicator and four cycles of 30 s
each at 60% power output). The lysate was clarified by centrifugation
at 30,000 × g for 30 min. Starting from a 1-liter
culture, the clarified supernatant was incubated for 1 h with
gentle shaking with 4 ml of chelating Sepharose Fast Flow Resin
preloaded with Ni2+ ions (Amersham Biosciences), previously
equilibrated in buffer A. The resin was washed with buffer A, and
NTAIL was eluted in buffer A containing 250 mM
imidazole. Eluates were analyzed by SDS-PAGE for the presence of
NTAIL. The fractions containing NTAIL were
combined; diluted with 5 volumes of 50 mM sodium phosphate, pH 8, 1 mM PMSF; and incubated for 1 h with gentle
shaking with 4 ml of Sepharose Q Fast Flow resin (Amersham
Biosciences). The flow-through was recovered, filtered onto 0.8-µm
filters (Pall Gelman Laboratories), and concentrated using a Centricon
Plus-20 concentrator (molecular mass cut-off, 5000 Da) (Millipore
Corp.). The protein was then loaded onto a Superdex 75 HR 10/30 column (Amersham Biosciences) and eluted in either 10 mM sodium
phosphate, pH 7, or 10 mM Tris/HCl, pH 8, 5 mM
EDTA. The protein was stored at
The pellet containing PCT was resuspended in 5 volumes (v/w) buffer B
(10 mM Tris/HCl, pH 8, 300 mM NaCl, 10 mM imidazole, 10% glycerol, 1 mM PMSF)
supplemented with 0.1 mg/ml lysozyme, 10 µg/ml DNase I, and protease
inhibitor mixture (Sigma) (50 µl/g of cells). After a 20-min
incubation with gentle agitation, the cells were disrupted by
sonication, and the lysate was clarified as described above. Starting
from a 1-liter culture, the clarified supernatant was incubated for
1 h with gentle shaking with 4 ml of Talon resin
(Clontech), previously equilibrated in buffer B. The resin was washed with buffer B, and PCT was eluted in buffer B
containing 50 mM EDTA. Eluates were analyzed by SDS-PAGE
for the presence of PCT. The fractions containing PCT were combined, filtered onto 0.8-µm filters (Pall Gelman Laboratories), and
concentrated using a Centricon Plus-20 concentrator (molecular mass
cut-off, 5000 Da) (Millipore Corp.). The eluate from the affinity
chromatography step was then loaded onto a Superdex 200 HR 10/30 column
(Amersham Biosciences) and eluted in 10 mM Tris/HCl, pH 8, 300 mM NaCl, 5 mM EDTA, 10% glycerol, and 1 mM PMSF. The protein was stored at
Purification of PNT and of N were carried out as described in (25, 48).
The 43-kDa N-terminal fragment of N, NCORE, was obtained by
limited trypsin digestion of N as described in Ref. 25, followed by gel
filtration onto a Superdex 200 HR 10/30 column (Amersham Biosciences).
NCORE was eluted with 50 mM Tris/HCl, pH 7.5, 1 mM PMSF and stored at
All purification steps, except for gel filtrations, were carried out at
4 °C.
Apparent molecular mass of proteins eluted from gel filtration columns
was deduced from a calibration carried out with low and high molecular
weight calibration kits (Amersham Biosciences). The theoretical Stokes
radii (RS) of a native (RSN) and
fully unfolded (RSU) protein with a molecular mass (MM) (in daltons) were calculated according to Ref. 44:
log(RSN) = 0.369 × log(MM) Determination of Protein Concentration--
Protein
concentrations were calculated either using the theoretical absorption
coefficients Mass Spectrometry--
Mass analysis of PCT was performed using
a Voyager DE RP mass spectrometer (PerSeptive Biosystems). Samples (0.7 µl containing 15 pmol) were mixed with an equal volume of sinapinic
acid matrix solution, spotted on the target, and then dried at room
temperature for 10 min. The mass standard was apomyoglobin.
Mass analysis of tryptic fragments of NTAIL was carried out
by digesting (0.25 µg of trypsin) 1 µg of purified
NTAIL obtained after separation onto 12% SDS-PAGE. The
experimental mass values of the tryptic fragments (determined as
described above) were compared with theoretical values found in protein
data bases (available on the World Wide Web at www.matrixscience.com
and www.expasy.ch/cgi-bin/findmod0.pl). The mass standards were either
autolytic tryptic peptides or keratin peptides.
Dynamic Light Scattering (DLS)--
Dynamic light scattering
experiments were performed with a Dynapro MSTC-200 (Protein Solutions)
at 20 °C. All samples were filtered prior to the measurements
(Millex syringe filters, 0.22 µm; Millipore Corp.). The
hydrodynamic radius was deduced from translational diffusion
coefficients using the Stokes-Einstein equation. Diffusion coefficients
were inferred from the analysis of the decay of the scattered
intensity autocorrelation function. All calculations were performed
using the software provided by the manufacturer.
Two-dimensional NMR--
A sample containing purified
NTAIL at a concentration of 0.5 mM in 10 mM sodium phosphate, pH 7, was used for the acquisition of
a NOESY spectrum on a DRX500 Bruker spectrometer at 300 K with 2048 complex points in the directly acquired dimension and 512 complex
points in the indirectly detected dimension. Solvent suppression was
achieved by the WATERGATE 3-9-19 pulse (45). The data were processed
using the UXNMR software; they were multiplied by a sine-squared bell
and zero-filled to 1 K in the first dimension prior to Fourier transformation.
Circular Dichroism--
The CD spectra were recorded on a Jasco
810 dichrograph using 1-mm thick quartz cells in 10 mM
sodium phosphate, pH 7, at 20 °C. Structural variations of
NTAIL were measured as a function of changes in the initial
CD spectrum upon the addition of either increasing concentrations of
2,2,2-trifluoroethanol (TFE) (Fluka) or different amounts of PCT, PNT,
or lysozyme (Sigma). CD spectra were measured between either 185 and
260 nm or 190 and 260 nm at 0.2 nm/min and were averaged from three
independent acquisitions. Mean ellipticity values per residue ([ Small Angle X-ray Scattering (SAXS)--
SAXS experiments were
carried out on beamline ID2 (47) at the European Synchrotron Radiation
Facility (Grenoble, France). Samples of purified NTAIL (in
buffer containing 10 mM Tris/HCl, pH 8, 5 mM
EDTA, with 10% glycerol as radiation scavenger) were filtered prior
each measurement (Millex syringe filters (0.22 µm); Millipore). The
wavelength was 1.0 Å, and the sample-to-detector distance was 3.0 and
1.0 m, leading to scattering vectors q ranging from
0.02 to 0.20 Å
The value of the radius of gyration (Rg) was
derived from the Guinier approximation (48):
I(q) = I(0)
exp(-q2Rg2/3),
where I(q) is the scattered intensity and
I(0) is the forward scattered intensity. The
radius of gyration and I(0) are inferred from the
slope and the intercept, respectively, of the linear fit of
Ln[I(q)] versus
q2 at low q values
(qRg < 1.0). The distance distribution function P(r) is the histogram of all of the interatomic
distances within a molecule. This function also provides the maximum
dimension Dmax of the molecule, which is defined
as the point where P(r) becomes zero. The
P(r) function was calculated by the Fourier inversion of the scattering intensity I(q) using
GNOM (49) and GIFT (50).
EM Studies--
5 µl of protein suspension (at ~0.1 mg/ml)
was loaded onto an air glow-discharged carbon-coated support grid for
30 s, washed in a 50-µl droplet of distilled H2O,
and then negatively stained with a 2% ammonium molybdate solution (pH
7.5). The structures formed by N and NCORE were imaged in a
JEOL 1200 EX II transmission electron microscope and recorded on Kodak
SO163 film at × 30,000 magnification under low electron dose conditions.
To make accurate measurements of nucleocapsid dimensions, micrographs
were digitized, on a Dunvegan Hi-Scan drum scanner (Dunvegan SA,
Lausanne, Switzerland), at a raster step size of 10 µm/pixel, corresponding to 3.4 Å/pixel in the specimen. 200 top views of nucleocapsid rings were selected by cross-correlation of scanned micrographs against a ring model of the appropriate dimensions and
excised into 90-pixel2 boxes using the SPIDER image
processing package (51). Rings were centered by cross-correlation
against a ring model, and radial density profiles were calculated for
each image. Average radial density profiles were calculated and plotted
using ORIGIN (Microcal).
Immunoprecipitation (IP) Studies of NTAIL--
IP
experiments were carried out using the anti-N mAbs Cl 25 and Cl 105 and
bacterial lysates expressing either tagged N and NTAIL or
no recombinant protein. The different bacterial cultures were induced
as described above, and 5-ml aliquots were pelleted and frozen at
The different aliquots were individually resuspended in 500 µl of
buffer C (10 mM Tris/HCl, pH 8, 0.1% Igepal, 150 mM NaCl) and sonicated (using a 750-watt sonicator and
three cycles of 7 s at 35% power output). The lysed aliquots were
centrifuged for 10 min at 16,000 × g at 4 °C, and
the supernatants, containing the soluble fractions, were recovered.
Soluble fractions (50 µl) were mixed with 4 µg of either Cl 25 or
Cl 105 anti-N mAb, 400 µl of buffer C were added in order to increase
the volume during the binding step, and the mixtures were incubated
with 20 µl of Protein G-Sepharose resin (Amersham Biosciences)
pre-equilibrated with buffer C. After a 1-h incubation with gentle
agitation at 20 °C, the mixtures were centrifuged, and the resin was
washed twice with 20 volumes of buffer C. It was then mixed with an
equal volume of 2× Laemmli sample buffer, boiled, and loaded onto a 12% SDS-PAGE gel.
Binding of NTAIL to P--
5-ml aliquots of
bacterial cultures expressing either NTAIL or P induced as
described above were harvested, and the cellular pellets were frozen at
An NTAIL and a P aliquot were individually resuspended in
500 µl of buffer D (10 mM Tris/HCl, pH 8, 20 mM imidazole, 0.5 M NaCl) and sonicated (using
a 750-watt sonicator and three cycles of 7 s at 35% power
output). The lysed aliquots were clarified by centrifugation at
16,000 × g for 10 min at 4 °C, and the
supernatants, containing the soluble fractions, were recovered. 250 µl of each of the two soluble fractions were mixed and immediately
incubated with 50 µl of chelating Sepharose fast flow resin preloaded
with Ni2+ ions (Amersham Biosciences), pre-equilibrated
with buffer D. After a 1-h incubation at 20 °C with gentle
agitation, the mixture was centrifuged, and the resin was washed five
times with 10 volumes of buffer D. It was then mixed with 50 µl of
2× Laemmli sample buffer, boiled, and loaded onto a 12% SDS-PAGE gel.
Sequence Analysis and Secondary Structure Predictions--
The
accession number of MV N is P04851. Deviation in amino acid composition
of NTAIL and NCORE were computed using the average amino acid frequencies of the SWISS-PROT data base (as obtained
from the World Wide Web at us.expasy.org/sprot) as the reference value.
The mean net charge (R) of a protein is determined as the
absolute value of the difference between the number of positively and
negatively charged residues divided by the total number of amino acid
residues. It was calculated using the program ProtParam at the EXPASY
server (available on the World Wide Web at www.expasy.ch/tools). The
mean hydrophobicity (H) is the sum of normalized
hydrophobicities of individual residues divided by the total number of
amino acid residues minus 4 residues (to take into account fringe
effects in the calculation of hydrophobicity). Individual
hydrophobicities were determined using the Protscale program at the
EXPASY server (available on the World Wide Web at www.expasy.ch/tools),
using the options "Hphob/Kyte & Doolittle," a window size of 5, and
normalizing the scale from 0 to 1. The values computed for individual
residues were then exported to a spreadsheet, summed, and divided by
the total number of residues minus 4 to yield H. HBoundary was computed as described by Uversky (31): HBoundary = (R + 1.15)/2.785.
Secondary structure predictions were carried out using the JPRED
program (available on the World Wide Web at
on.ebi.ac.uk/servers/jpred.html) (52).
MV N is a modular protein composed of two regions: a well
conserved N-terminal moiety, NCORE (aa 1-399) and a
hypervariable C-terminal moiety, NTAIL (aa 400-525) (see
Fig. 1A). The sequence variability and the sensitivity to proteolysis of NTAIL (4, 28) are both hallmarks of intrinsic disorder (29, 53). We have thus
analyzed the sequence properties of NTAIL in order to check
whether this domain possesses the features typical of intrinsically disordered proteins.
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactopyranoside was added to a final
concentration of 0.2 mM, and the cells were grown at 37 °C for 3 h. The induced cells were harvested, washed, and
collected by centrifugation. The resulting pellets were frozen at
20 °C.
20 °C in the presence of 10% glycerol.
20 °C.
20 °C in the presence of 20% glycerol.
0.254, and log(RSU) = 0.533 × log(MM)
0.682. The hydrodynamic volume (V) was calculated from the
Stokes radius as V = 4/3
RS3. The theoretical
hydrodynamic volumes of a native (VN), natively
unfolded random coil (VNUcoil), and natively unfolded premolten globule (VNUpmg) protein
of n residues were calculated according to Ref. 31:
log(VN) = (2.197 ± 0.037) + (1.072 ± 0.015) × log n,
log(VNUcoil) = (1.997 ± 0.078) + (1.498 ± 0.035) × log n, and log(VNUpmg) = (2.33 ± 0.12) + (1.234 ± 0.047) × log
n.
(mg/ml·cm) at 280 nm as obtained using the program
ProtParam at the EXPASY server (available on the World Wide Web at
www.expasy.ch/tools), or the Bio-Rad protein assay reagent
(Bio-Rad).
])
were calculated as [
] = 3300 m ×
A/(lcn), where l represents
path length (0.1 cm), n is the number of residues,
m is the molecular mass in daltons, and c is the
protein concentration expressed in mg/ml. Numbers of residues
(n) are 139 for NTAIL, 236 for PNT, 284 for PCT,
and 129 for lysozyme, whereas m values are 15,300 Da for
NTAIL, 24,800 Da for PNT, 30,800 Da for PCT, and 14,300 Da
for lysozyme. Protein concentrations of 0.1 mg/ml were used when
recording individual spectra. Protein concentrations ranging from 0.1 to 0.15 mg/ml were used when recording spectra of protein mixtures. In
this case, mean ellipticity values per residue ([
]) were
calculated as [
] = 3300
A/{[(C1n1)/m1) + (C2n2/m2)]
l}, where l represents path length (0.1 cm),
n1 or n2 is number of
residues, m1 or m2 is
molecular mass in daltons, and c1 or
c2 is protein concentration expressed in mg/ml
for each of the two proteins in the mixture. The theoretical average
ellipticity values per residue ([
]Ave) expected,
assuming that neither any unstructured-to-structured transition nor any
secondary structure rearrangement occurs, were calculated as follows:
[
]Ave = [([
]1n1) + ([
]2n2R)]/(n1 + n2R), where [
]1
and [
]2 correspond to the measured mean ellipticity values per residue, n1 and
n2 to the number of residues for each of the two
proteins, and R to the excess molar ratio of protein 2. The
-helical content was derived from the ellipticity at 220 nm as
described in Ref. 46.
1 and 0.05 to 0.40 Å
1,
respectively. The scattering vector is defined as q = 4
/
sin
, where 2
is the scattering angle. The detector was
an X-ray image intensified optically coupled to a FReLoN CCD camera
developed by the European Synchrotron Radiation Facility. 40 successive frames of 0.7 s with a 5-s pause between each frame
were recorded for each sample. The protein solution was circulated
through an evacuated quartz capillary between each frame. Thus, no
protein solution was irradiated longer than 0.7 s. Each frame was
then carefully inspected to check for possible bubble formation or radiation-induced aggregation. No such effect was observed, and individual frames could then be averaged. Absolute calibration was made
with a Lupolen sample. A series of measurements at different protein
concentrations ranging from 1.8 to 9 mg/ml were performed to check for
interparticle interaction. Background scattering was measured before or
after each protein sample using the buffer solution and then subtracted
from the protein scattering patterns after proper normalization and
correction from detector response. All of the experiments were carried
out at 8 °C.
20 °C.
20 °C.
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
View larger version (26K):
[in a new window]
Fig. 1.
A, domain organization of MV N and
sequence composition of NTAIL. Top, domain
organization of N showing that it is composed of two regions,
NCORE (aa 1-399) and NTAIL (aa 400-525). The
epitopes recognized by the anti-N mAbs, Cl 25 mAb (aa 457-476) and Cl
105 mAb (aa 519-525), are shaded and indicated by
one or two asterisks, respectively.
The approximate location of the N-N, N-P, and RNA-binding regions are
indicated below N. Bottom, deviation
in amino acid composition from the average values in the Swiss-Prot
data base of NTAIL. The relative enrichment of
order-promoting (white bars) and
disorder-promoting residues (shaded bars) is
shown. B, purification of NTAIL. Coomassie Blue
staining of a 12% SDS-PAGE. TF, bacterial lysate (total
fraction); SN, clarified supernatant (soluble fraction);
IMAC, eluent from immobilized metal affinity chromatography;
IIEC, eluent from inverse ion exchange chromatography
(nonretained fraction from ion exchange chromatography); GF,
eluent from gel filtration. C, elution profile of
NTAIL from gel filtration. The main peak containing
NTAIL is highlighted, and the molecular mass
deduced from the column calibration is shown.
Domain Organization of N and Sequence Properties of NTAIL-- The amino acid composition of NTAIL and the deviation from the average values in the SWISS-PROT data base are shown in Fig. 1A. NTAIL has a peculiar composition, being depleted in all "order-promoting" residues (Trp, Cys, Phe, Tyr, Ile, Leu) and enriched in most "disorder-promoting" residues (Arg, Gln, Ser, and Glu), as already described for intrinsically disordered proteins (32) (Fig. 1A). Moreover, NTAIL is predicted to be natively unfolded by the PONDR predictor of naturally disordered regions (54), as well by the method based on the mean hydrophobicity/mean net charge ratio (55) (data not shown). Finally, NTAIL has little predicted secondary structure, a feature that has been recently noticed in protein regions with "no ordered regular structure" (56).
In order to directly investigate the structural properties of NTAIL, we have expressed, purified, and characterized the NTAIL domain alone.
Expression and Purification of NTAIL-- Most NTAIL was recovered from the soluble fraction of bacterial lysates (Fig. 1B, lane SN). NTAIL was purified to homogeneity (>95%) in three steps: immobilized metal affinity chromatography (IMAC), inverse ion exchange chromatography, and gel filtration (Fig. 1B). The identity of the recombinant product was confirmed by mass spectrometry analysis of the tryptic fragments obtained after digestion of purified NTAIL. As shown in Fig. 1B, NTAIL displays an abnormally slow migration in SDS-PAGE even after heat denaturation. In particular, it migrates with an apparent molecular mass (MM) of 20 kDa, whereas the expected MM is 15 kDa. This abnormal behavior has already been observed in the case of the intrinsically disordered MV PNT (41) as well as in other intrinsically disordered proteins and can most likely be ascribed to their unusual sequence composition (30).
Size Exclusion Chromatography of NTAIL-- NTAIL (15 kDa) is eluted from the gel filtration column as a peak corresponding to a 36-kDa globular protein (Fig. 1C). The same profile is obtained regardless of the nature of the buffer used and the presence of different NaCl concentrations (not shown), thus excluding the possibility that the observed behavior could be ascribed to nonspecific interactions of NTAIL with the column matrix. The sharpness of the peak indicates the presence of a well defined species. The elution volume of a protein from a gel filtration column depends on its hydrodynamic properties. The hydrodynamic radius of a protein (Stokes radius (RS)) can be deduced from its apparent MM (as seen by gel filtration) (44). The apparent MM of 36 kDa measured for NTAIL corresponds to a Stokes radius of 27 ± 3 Å. On the other hand, the theoretical Stokes radius of a monomeric, native (RSN) or fully unfolded (RSU) protein can be estimated according to the equations described in Ref. 44. In the case of NTAIL, RSN = 19 Å and RSU = 35 Å. Therefore, the Stokes radius experimentally measured for NTAIL (27 Å) is not compatible with a monomeric, globular protein. Rather, such a large value of the Stokes radius can be attributed either to dimerization or to an extended conformation.
DLS Studies on NTAIL-- The hydrodynamic radius of proteins can also be derived by dynamic light scattering studies, since diffusion coefficients of proteins depend upon their size and shape. Globular proteins differ notably from fully or partly unstructured proteins in their hydrodynamic properties, and an empirical relationship between number of residues and hydrodynamic radius RS has been established for native, globular proteins and for fully denatured proteins (57). The hydrodynamic radius measured for NTAIL by DLS is RS = 30 ± 2 Å, in either 10 mM sodium phosphate, pH 7, or 10 mM Tris/HCl, pH 8, 75 mM NaCl at a concentration of 1.25 mg/ml. This value is consistent (within the error bars) with the RS value measured by gel filtration and corresponds to a hydrodynamic volume (V) of ~97,000 Å3. According to the equations described by Uversky (31), the theoretical V expected for a native, globular protein composed of 139 residues is about 31,000 Å3, whereas for a fully denatured protein it would be close to 180,000 Å3. Thus, the V of NTAIL calculated by DLS is about 3 times larger than the value expected for a globular protein and half of that expected for a denatured, fully unfolded protein. Rather, these hydrodynamic properties are consistent with the hypothesis that NTAIL is a native premolten globule (31).
NMR Experiments on NTAIL--
In order to investigate
its actual conformation, NTAIL was studied by
two-dimensional NMR spectroscopy. Fig.
2A shows the amide region of a
NOESY spectrum. The very small spread of the resonance frequencies for
amide protons (between 7.8 and 8.7 ppm; see frame in Fig.
2A) together with the scarcity of nuclear Overhauser effects
in the amide-amide region are typical of a protein without any stable
secondary structure. Moreover, the line width related to NH resonance
frequencies is in accordance with the molecular size of a monomeric
form of NTAIL.
|
CD Studies on NTAIL--
The far-UV CD spectrum of
NTAIL at neutral pH is typical of an unstructured protein,
as seen from its large negative ellipticity at 198 nm and very low
ellipticity at 185 nm (Fig. 2B). However, the observed
ellipticity values at 200 and 222 nm (9700 and
2400 degrees
cm2 dmol
1, respectively) (Fig. 2B)
are consistent with the existence of some residual secondary structure,
typical of the premolten globule state (39). Therefore, the
spectroscopic and hydrodynamic parameters, together with the peculiar
sequence properties of NTAIL, converge to show that
NTAIL is mostly unstructured in solution and that it
belongs to the class of natively unfolded or intrinsically disordered/unstructured proteins (37, 38, 42, 61, 62).
The majority of intrinsically disordered proteins folds upon binding to
their physiological partner(s) (37). The solvent TFE mimics the
hydrophobic environment experienced by proteins in protein-protein
interactions and is therefore widely used as a probe to discover
regions that have a propensity to undergo an induced folding (58).
Thus, we recorded CD spectra of NTAIL in the presence of
increasing concentrations of TFE (Fig. 2B). NTAIL shows an increasing gain of -helicity upon the
addition of TFE, as indicated by the characteristic maximum at 190 nm
and minima at 208 and 222 nm (Fig. 2B). Most
unstructured-to-structured transitions take place in the presence of
20% TFE, a concentration at which the
helix content is estimated
to be about 22% (using the ellipticity at 220 nm). The gain of
-helicity induced by TFE, although already reported for other
proteins, including MV PNT (41), is not a general rule; for instance,
the acidic activator domain of GCN4 forms little or no
-helix in TFE
concentrations as high as 30% and folds mostly as
-sheets in 50%
TFE (59). In the case of NTAIL, the use of TFE reveals a
clear
-helix forming potential within this protein domain.
Interestingly, this observation is in agreement with the secondary
structure prediction made by the JPRED program (52), which predicts an
-helix (residues 489-504) as the only secondary structure element
within NTAIL.
SAXS Studies--
SAXS studies are particularly well adapted to
study flexible, low compactness or even extended macromolecules in
solution. They provide low resolution structural data and give access
to the mean particle size (radius of gyration,
Rg) as well as to the maximal intramolecular
distance (DMAX). These two parameters give
information on the degree of compactness of the molecule, and the
latter gives an idea of the maximal degree of extension reached by the
molecule in solution. Fig. 3A
shows the Guinier plots of the SAXS data of NTAIL at four
different concentrations. Each curve can be well approximated by a
straight line in the Guinier region (qRg < 1.0). The slope gives the value of the radius of gyration,
Rg, whereas the intercept of the straight line
gives the I(0), which is proportional to the MM of the
scatterer. The Rg extrapolated at zero
concentration is 27.5 ± 0.7 Å, and the deduced MM is 15,250 Da,
which is in perfect agreement with the expected MM for a monomeric form
(15,300 Da). A similar Rg value (26.9 ± 0.8 Å) has been obtained using the method based on the Debye function
(60, 61). According to data already available in the literature (57,
62-64), the expected Rg of NTAIL
would be 15 Å for a globular protein and around 35-38 Å for a
denatured, fully unfolded protein. Therefore, the observed
Rg indicates that NTAIL is not
globular. However, the protein is more compact than a random coil,
suggesting that it possesses some residual structure.
|
A very useful method to describe the structural properties of a
molecule is the Kratky plot. In particular, one can from the shape of
this plot infer the conformation adopted by the molecule. The Kratky
plot of a globular protein has a typical bell shape with a clear
maximum. For a completely unfolded protein or in a premolten globule
conformation, no such maximum can be observed, and the curve displays a
plateau (65). The Kratky plot of NTAIL displays a bump at
q 0.08 Å
1 followed by a plateau for
q > 0.15 Å
1 (see Fig. 3B).
The absence of a maximum clearly indicates that NTAIL is
not globular and does not possess a tightly packed core. However, the
observed bump may be indicative of some residual structure.
The distance distribution function, deduced from the scattering intensities of NTAIL (data not shown), has a bell shape, with a maximum dimension Dmax of 120-130 Å. This value, while being indicative of an extended, nonglobular conformation, is lower than expected for a random coil (62, 63).
All in all, the hydrodynamic properties of NTAIL inferred from gel filtration, DLS and SAXS, indicate that NTAIL adopts a typical nonglobular, premolten globule conformation in solution. Accordingly, it is more compact than a random coil and retains some residual secondary structure, in agreement with the CD studies. In conclusion, the spectroscopic and hydrodynamic properties of NTAIL, together with its peculiar sequence composition, converge to show that it is a natively unfolded protein, belonging to the premolten globule subfamily.
Comparison of N and NCORE by EM Studies-- N produced in MV-infected cells (66) as well as recombinant MV N (4-6) forms nucleocapsids with a characteristic herringbone structure. In order to investigate whether the NTAIL domain affects the conformation of N within nucleocapsids, we have analyzed by EM the nucleocapsid-like structures formed by either MV N or by a truncated form devoid of the NTAIL moiety (NCORE). NCORE was obtained by limited proteolysis of purified N as described in Ref. 4, followed by gel filtration (data not shown).
EM analysis of full-length N reveals the presence of typical
nucleocapsid-like, herringbone structures ranging in length from 20 to
80 nm (Fig. 4A,
left panel, arrows). However, most of
the nucleocapsid-like particles appear as rings with a mean diameter of
20 nm (Fig. 4A, left panel,
feathered arrows). These rings correspond to
shorter nucleocapsids viewed along their axis, and their abundance
suggests an intrinsic fragility in nucleocapsids formed by the
bacterially expressed full-length nucleoprotein. Similar rings have
also been described in Ref. 3.
|
Electron microscopy of NCORE, however (Fig. 4A, right panel), reveals a predominance of rigid helices up to 400 nm long, as previously described (22, 23). This indicates that the removal of the exposed NTAIL region appears to stabilize the interaction between turns of the helical nucleocapsid, either rendering it more robust or allowing short helices and rings to polymerize giving rise to longer helices. Radial density profiles, calculated from N and NCORE rings (Fig. 4B), combined with visual inspection of negative stain images, reveals no obvious extra density in N, in agreement with previous data (22, 23). This suggests that NTAIL is not visible as a distinct structural domain, because it is either poorly visualized due to its flexible nature or it is tightly associated with NCORE, as has been demonstrated for the C terminus of rabies virus N (67).
The intrinsic flexibility of NTAIL may sterically interfere with the formation of a stable interaction between successive turns of the helical nucleocapsid. The association of these rings gives rise to more rigid helical structures when imaged by negative stain EM. Therefore, the intrinsic disorder of NTAIL provides a structural explanation for the observed gain of rigidity of NTAIL-free nucleocapsids.
Epitope Exposure of NTAIL and Binding to P--
In
order to check whether the isolated NTAIL domain conserves
a conformation similar to that adopted within the full-length N, we
have performed IP studies using the anti-N Cl 25 and Cl 105 mAbs. These
mAbs recognize the linear epitopes 457-476 and 515-525 of MV N,
respectively. These mAbs are able to precipitate both N and
NTAIL from bacterial lysates (see Fig.
5A, lanes
N and Nt), whereas no such bands are observed
with a control bacterial lysate, thus confirming the specificity of the
IP (see Fig. 5A, lanes C). Thus, these
two epitopes are equally accessible within the full-length protein and
within the isolated NTAIL domain. This suggests that no
dramatic conformational changes take place in the isolated
NTAIL domain compared with the full-length N.
|
As discussed above, MV NTAIL is required for stable binding of N to P (18, 20, 26). To determine whether the isolated NTAIL domain was able to bind P, we tested the ability of bacterial lysates expressing hexahistidine tagged NTAIL to pull down untagged P onto an IMAC resin. The IMAC resin selectively pulled down NTAIL expressed alone but not the untagged P expressed alone (Fig. 5B, lanes Nt and P). When both lysates were mixed, the IMAC resin selectively pulled down NTAIL together with an additional protein that has the same electrophoretic mobility of P (Fig. 5B, lane Nt + P). The identity of this protein band was confirmed by Western blotting using an anti-P mAb (data not shown), thus proving that the NTAIL domain on its own is able to bind its physiological partner in bacterial lysates.
P, the Physiological Partner of NTAIL-- As already mentioned, a large majority of natively unfolded proteins or protein domains characterized so far undergo disorder-to-order transitions in the presence of their physiological partner(s) (32, 33, 35, 37). The availability of the physiological partner of NTAIL enables us to check for the occurrence of such unstructured-to-structured transitions.
The P protein of MV consists of an N-terminal moiety (aa 1-230), PNT, responsible for binding to NCORE within the N°·P complex (26), and of a C-terminal moiety (aa 231-507), PCT, responsible for binding to NTAIL in both N°·P and NNUC·P complexes (9, 68). We have recently shown that the PNT domain of MV P is intrinsically disordered when expressed alone (41) and probably also in the context of full-length P.3 Therefore, the interaction between NTAIL and P may result in a possible induced folding of PNT concomitantly to the possible induced folding of NTAIL. Since the purified PNT domain was already available (41), we purified the PCT moiety in order to monitor the possible structural transitions of NTAIL in the presence of either PNT or PCT.
Most bacterially expressed PCT is found in the soluble fraction of the bacterial lysate (data not shown). Purification consists of two steps, IMAC followed by gel filtration. The expected MM of the purified product (31 kDa) was confirmed by mass spectrometry. However, PCT migrates in SDS-PAGE as a 36-kDa protein (see Fig. 5C). This discrepancy may be due to the presence of a region (aa 231-307 of P) of peculiar composition (rich in Gly, Ser, Ala, and Glu) at the N terminus of PCT. Although PCT is eluted from the gel filtration column as a very broad peak (not shown), DLS studies have shown the presence of a major (97%) species with a MM of ~200 kDa. This MM may correspond either to a high degree of oligomerization or to a very elongated shape of the protein or to both, as in the case of Sendai virus (SeV) PCT (69).
The eluent from the gel filtration column (see Fig. 5C) contains several protein species. Western blot analysis with an anti-hexahistidine tag mAb (not shown) showed that the different protein bands are degradation products. Among the different products, two major bands are present (see the arrows in Fig. 5C), the lower of which corresponds to a truncated form devoid of an 8-kDa C-terminal fragment (see arrow 2 in Fig. 5C). Mass spectrometry analysis of PCT allowed the precise identification of the cleavage site at position 436 of P, thus indicating that this region is flexible and exposed to the solvent.
Does NTAIL Undergo an Induced Folding in the Presence of PCT?-- To monitor possible structural transitions of NTAIL in the presence of PCT, we have used far-UV CD spectroscopy.
The CD spectrum of purified PCT (see Fig.
6A, gray
line) is typical of a protein with a predominant -helical
content, as seen by the positive ellipticity between 185 and 200 nm and
by two minima at 208 and 222 nm. The
-helical content (estimated as
37% based on the ellipticity at 220 nm) is in agreement with structural data on SeV PCT domains (70, 71). After mixing NTAIL with different molar excesses of PCT, the observed CD
spectra of the mixtures differ from the corresponding theoretical
average curves calculated from the individual spectra. Since the
theoretical average curves correspond to the spectra that would be
expected if no structural variations occur, deviations from these
curves point out structural transitions. Most pronounced structural
transitions are observed with an NTAIL/PCT molar ratio of
1:1.5 (Fig. 6A). When equimolar amounts are used, only
slight deviations from the theoretical average curve are observed; the
two spectra are almost perfectly superimposable except for the
185-195-nm region, in which a 30% increase of ellipticity is observed
(data not shown). In the presence of molar excesses of PCT, a random
coil to
-helix transition can be observed, as indicated by the much
more pronounced minima at 208 and 222 nm and by the higher ellipticity
at 190 nm of the experimentally observed spectra compared with the
corresponding theoretical average curves (Fig. 6A).
Moreover, the
-helical contents of the mixtures (ranging from 38 to
48% at different molar ratios, with the highest value being obtained
with a 1.5-fold excess of PCT) are not only higher than those of the
corresponding theoretical average curves, but are also higher than the
-helical content of PCT alone. Gradually increasing the
concentrations of PCT to molar ratios as high as 5 does not result in
more drastic structural variations than those observed at a
1.5-fold molar excess of PCT (data not shown).
|
As a control, we recorded CD spectra of lysozyme either alone or mixed
with NTAIL at different molar ratios. As shown in Fig. 6B (gray line), the lysozyme spectrum
is typical of an /
protein, in agreement with structural data
(72). Mixing equimolar amounts of the two proteins does not result in
any significant structural variations. The experimentally measured CD
spectrum of the mixture is in fact superimposable on the theoretical
average curve (see Fig. 6B), as expected if no interaction
occurs between lysozyme and NTAIL. The same results were
obtained at a 5-fold excess of lysozyme (data not shown).
As shown in Fig. 6C, no significant structural variations are observed with equimolar amounts of NTAIL and PNT, with all spectra being typical of unfolded proteins. The same results were obtained by gradually increasing the amounts of PNT to molar excesses as high as 5 (data not shown). These results can be accounted for by assuming either that the two proteins do not interact, in agreement with the results reported in the literature (9, 68), or that the interaction does not imply any concomitant unstructured-to-structured transition.
The quite good superimposition between experimental and theoretical curves observed when mixing NTAIL with either PNT or lysozyme (both at different molar excesses) confirms the significance of the deviation observed in the case of the NTAIL-PCT mixtures (see Fig. 6A). Therefore, these results indicate that NTAIL undergoes an induced folding upon binding to PCT.
A pioneering study has recently demonstrated that an intrinsically
disordered protein region is in fact structured in living cells (73).
FlgM, a 97-residue protein from Salmonella typhimurium, which regulates flagellar synthesis by binding the transcription factor
28, is fully unstructured in vitro (74).
However, NMR performed on living E. coli overexpressing FlgM
showed that the C terminus of FlgM is in fact structured in
vivo, in the same manner as it becomes structured upon binding to
28 in vitro, whereas its N terminus remains
unstructured. Furthermore, the same gain of structure is observed
in vitro in the presence of >400 g/liter glucose (73).
In order to check whether such solute-induced structural transitions
could be observed also in the case of NTAIL, we have recorded a CD spectrum of NTAIL in the presence of 440 g/liter glucose (Fig. 6D). As shown in Fig. 6D,
the spectrum obtained is still characteristic of an unfolded protein,
and is similar to the spectrum obtained in the absence of glucose.
According to Dedmon et al. (73), these results suggest that
NTAIL would belong to the class of intrinsically disordered
proteins that "do not become structured at physiologically relevant
solute concentrations" and that require a physiological partner to fold.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The high proteolytic sensitivity of NTAIL, together with its peculiar sequence properties, strongly suggests that it is mostly unstructured.
The hydrodynamic properties of NTAIL inferred from both gel filtration and DLS experiments are consistent with NTAIL being either a stable globular dimer or a monomeric, extended protein. Using NMR and CD, we show that NTAIL is monomeric and mostly unstructured. However, its far-UV spectroscopic parameters indicate that NTAIL is not fully unfolded, but rather it conserves a residual secondary structure content typical of natively unfolded proteins with a premolten globule conformation (31).
The scattering patterns obtained by SAXS show that NTAIL is a nonglobular protein. However, it retains a certain degree of compactness, as seen by the Rg and Dmax values. The structural properties of the polypeptide chain can also be determined by the RS/Rg ratio. This ratio should be (3/5)1/2 for a globular protein, around 0.9 for a premolten globule, and ~1.5 for a random coil (75). In the case of NTAIL, the RS and Rg values obtained by DLS and SAXS, respectively, lead to a ratio of 1.1, which is consistent with a premolten globule. Moreover, the mean hydrodynamic volume inferred from gel filtration and DLS studies (~97,000 Å3) is in agreement with the value expected for a native premolten globule (about 94,000 Å3) (31).
In addition, NTAIL lies in a region of the hydrophobicity
versus net charge plot, which is typical of native premolten
globules (31). In particular, intrinsic coils are more
distant from the border between rigid and intrinsically unstructured
proteins than intrinsic premolten globules. In the case of
NTAIL, the distance value from the border
(Hboundary H) is 0.05 (see under
"Experimental Procedures"), which is consistent with the value
expected for a native premolten globule (0.037 ± 0.033) (31).
Thus, NTAIL can be described as a nonglobular polypeptide chain, more compact than a random coil, containing a significant amount of residual structure. This residual structure may prevent the polypeptide chain from adopting multiple conformations. In agreement, the distribution of the conformations of NTAIL is narrow, as seen by the relative sharpness of the elution peak observed in gel filtration, compared with what would be expected for a fully denatured protein in the presence of chaotropic agents (urea, guanidinium chloride). The residual ordered secondary structure of NTAIL may arise from dynamic breaking and reforming of interactions. We can reasonably speculate that these residual interactions could enable a more efficient start of the folding process induced by a binding partner.
The intrinsic disorder of NTAIL provides a possible structural explanation for the observed increase in rigidity of NTAIL-free nucleocapsids. The removal of the NTAIL region by limited proteolysis leads to a more rigid nucleocapsid, as indicated by the fact that EM micrographs of NCORE mostly contain herringbone structures, as opposed to EM images of N, which mainly contain rings. The presence of flexible regions at the surface of the viral nucleocapsid would ideally enable the viral ribonucleoproteic complex to have plastic interactions with several partners, such as the polymerase complex (L·P) but also possibly components of the cell cytoskeleton (76, 77). Striking changes in nucleocapsid conformation in response to either increasing salt concentrations or limited proteolysis have already been described (22, 23, 78) and point out the plasticity of its helical structure. This plasticity suggests that changes in the microenvironment of the nucleocapsid could affect its conformation during viral RNA transcription and replication, or during virus assembly, processes in which modifications in the coiling of the nucleocapsid could be important.
Most natively unfolded proteins or protein domains characterized so far
undergo some degree of folding in the presence of a physiological
partner (see Refs. 32, 33, 35, and 37). After showing that
NTAIL alone still conserves the ability to bind P, we have
studied by far-UV spectroscopy the possible structural transitions of
NTAIL in the presence of PCT and PNT. CD is the method of
choice to monitor such structural variations, since a residual
structural content as low as 10-20% can be determined by this method.
Indeed, this method turned out to be sensitive enough to detect
unstructured-to-structured transitions upon binding of
NTAIL to PCT, whereas no structural transitions were
detected in the presence of either PNT or lysozyme. In particular,
binding of NTAIL to PCT results in a strong
unstructured-to-structured transition rather than in minor local
structural changes, as shown by the considerable gain of -helicity
of the mixture (48%) compared with PCT (37%). The gain of
-helicity of NTAIL observed in the presence of different
molar excesses of PCT is in agreement with the strong
-helical
propensity of NTAIL pointed out in experiments using TFE.
The highest
-helical content has been obtained with a 1.5-fold
excess of PCT. A possible interpretation for this result may come from
analysis of purified PCT. As shown in Fig. 5C, purified PCT
consists of two major bands: a full-length form and a truncated form
devoid of the last 70 C-terminal residues, the relative abundance of
which can be roughly estimated to be 70 and 30%, respectively. Biochemical data on SeV have shown that the extreme C terminus (aa
479-568) of PCT contains the region responsible for binding to N (79,
80). Accordingly, it is possible that in the purified PCT sample only
the upper band may participate to the interaction with
NTAIL. Therefore, a 1.5-fold excess of PCT may indeed
correspond to an equimolar ratio between NTAIL and a form
of PCT able to make a productive interaction. On the other hand, in the
presence of lower amounts of PCT, such as those used in the equimolar
mixture, only very slight structural transitions are observed, even if 70% of NTAIL is expected to be complexed to PCT. Thus, the
gain of structure of NTAIL does not seem to take place
gradually but rather follows a cooperative transition, where the
midpoint transition is just below 1.5-fold molar excess of PCT.
Such a cooperative transition is typical of protein folding/unfolding
processes. Increasing the molar excess of PCT beyond 1.5-fold
does not result in any stronger unstructured-to-structured transitions.
This may reflect the formation of a 1:1 stoechiometric complex.
Therefore, at concentrations of PCT above those required for the
formation of such a complex, no more NTAIL would be
available for binding to PCT, and saturation of the system would be achieved.
These results indicate that NTAIL folds upon binding to its physiological partner, P. However, the possibility that the observed disorder-to-order transitions may also concern flexible regions within PCT is an open question. In this regard, indications are expected to arise from further structural studies, in particular crystallographic studies of NTAIL-PCT complexes. In addition, we point out that the studies presented in this paper do not allow us to answer the question as to whether the gain of structure of NTAIL takes place in the NNUC·P or in the N°·P complex, or in both. Further studies are required to discriminate among these possibilities.
The intrinsic disorder is abundant within the replicative complex of MV, as indicated by experimental evidence accumulated on PNT and NTAIL. Furthermore, in this paper, we report biochemical evidence suggesting that MV P possesses an additional flexible region, as indicated by the protease sensitivity observed within PCT. These results are in agreement with biochemical and structural data on SeV P, indicating the presence of a flexible linker, sensitive to proteolysis within the 447-517 region (69-71).
One advantage of unstructured regions of proteins might be their
ability to bind to a wide variety of structurally distinct substrates
with a weak affinity (32, 35). The pattern of interactions of
NTAIL is consistent with this hypothesis; NTAIL
takes part in numerous interactions with different protein partners,
including P (both within N°·P and NNUC·P), the
polymerase complex P·L, M (27), the interferon regulatory factor 3 (81), and possibly components of the cell cytoskeleton (76,
77). Moreover, NTAIL within viral nucleocapsids released from infected cells also binds to the human immunoglobulin G receptor FcRII, provoking partial immunosuppression (82, 83). Finally, a
conserved, hydrophobic patch at the extreme C terminus of
Morbillivirus NTAIL has been described to bind
to the heat-shock protein Hsp72, which modulates the level of
viral RNA synthesis (25). This is coherent with the proposal that in
addition to their function of promoting protein folding, some
chaperones bind hydrophobic patches in intrinsically disordered
proteins, modulating their accessibility and/or their sensitivity to
proteolysis (32).
NTAIL plays very different roles during viral replication, being involved in RNA transcription, RNA replication, and viral assembly. One role of NTAIL in actively replicating nucleocapsids could be to put into contact several proteins within the replicative complex, such as the N°·P and the P·L complexes. One can speculate that the gain of structure of NTAIL upon binding to its physiological partner could result in stabilization of the N·P complex. The increased rigidity of NTAIL would lead to a decrease in the number of conformations adopted by NTAIL in solution and thereby to an increased affinity for its target. At the same time, folding of NTAIL would result in a modification in the pattern of solvent-accessible regions, resulting in the shielding of specific regions of interaction. As a result, NTAIL would no longer be available for binding to its other partners.
This paper provides new perspectives in the study of disordered regions
within the MV replicative complex; in particular, the gain of structure
arising from the interaction with the physiological partner may lead to
protein complexes rigid enough to allow crystallization. The crystal
structure determination of such complexes would represent an important
step toward the understanding of the molecular mechanism of N and P.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank M. C. Trescol-Biémont and C. Rabourdin-Comble for kindly providing the plasmid encoding NTAIL, A. Mosbah for help with the NMR study, M. Desmadril for critical advice with CD, and D. Gerlier for the anti-N and anti-P monoclonal antibodies. We thank D. Gerlier and J. Curran for critical reading of the manuscript. We thank K. Dunker for useful discussions.
![]() |
FOOTNOTES |
---|
* This work was supported in part by the CNRS. This study has been carried out with financial support from the Commission of the European Communities, specific program "Quality of Life and Management of Living Resources," QLK2-CT2001-01225, "Towards the Design of New Potent Antiviral Drugs: Structure-Function Analysis of Paramyxoviridae RNA Polymerase."The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: ESIL-CNRS-AFMB Case 925, 163, avenue de Luminy, 13288 Marseille Cedex 09, France. Tel.: 33-4-91-82-86-47; Fax: 33-4-91-82-86-46; E-mail: longhi@afmb.cnrs-mrs.fr.
¶ Supported by a grant from the Fondation pour la Recherche Médicale. Present address: Ecole de l'ADN, Association Grand Luminy, Case 922, Bât CCIMP, 13288 Marseille Cedex 09, France.
Supported by a postdoctoral fellowship from the EMBO.
Published, JBC Papers in Press, March 5, 2003, DOI 10.1074/jbc.M300518200
2 J. Chadwick and T. F. Wild, unpublished data.
3 S. Longhi, K. Johansson, D. Karlin, and B. Canard, unpublished data.
![]() |
ABBREVIATIONS |
---|
The abbreviations used are: MV, measles virus; N, nucleoprotein; N°, soluble, monomeric form of N; P, phosphoprotein; L, RNA-dependent RNA polymerase; M, matrix protein; EM, electron microscopy; PCT, C-terminal moiety of P; PNT, N-terminal moiety of P; PMSF, phenylmethylsulfonyl fluoride; RS, Stokes radius; RSN, Stokes radius for a native protein; RSU, Stokes radius for an unfolded protein; MM, molecular mass; V, hydrodynamic volume; DLS, dynamic light scattering; SAXS, small angle X-ray scattering; TFE, 2,2,2-trifluoroethanol; Rg, radius of gyration; IP, immunoprecipitation; R, mean net charge; H, mean hydrophobicity; IMAC, immobilized metal affinity chromatography; SeV, Sendai virus; mAb, monoclonal antibody; aa, amino acids.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. | Curran, J., and Kolakofsky, D. (1999) Adv. Virus Res. 54, 403-422[Medline] [Order article via Infotrieve] |
2. | Lamb, R. A., and Kolakofsky, D. (2001) in Fields Virology (Fields, B. N. , Knipe, D. M. , and Howley, P. M., eds), 4th Ed. , pp. 1305-1340, Lippincott-Raven, Philadelphia, PA |
3. | Warnes, A., Fooks, A. R., Dowsett, A. B., Wilkinson, G. W., and Stephenson, J. R. (1995) Gene (Amst.) 160, 173-178[CrossRef][Medline] [Order article via Infotrieve] |
4. | Karlin, D., Longhi, S., and Canard, B. (2002) Virology 302, 420-432[CrossRef][Medline] [Order article via Infotrieve] |
5. | Fooks, A. R., Stephenson, J. R., Warnes, A., Dowsett, A. B., Rima, B. K., and Wilkinson, G. W. (1993) J. Gen. Virol. 74, 1439-1444[Abstract] |
6. |
Bhella, D.,
Ralph, A.,
Murphy, L. B.,
and Yeo, R. P.
(2002)
J. Gen. Virol.
83,
1831-1839 |
7. | Spehner, D., Kirn, A., and Drillien, R. (1991) J. Virol. 65, 6296-6300[Medline] [Order article via Infotrieve] |
8. | Spehner, D., Drillien, R., and Howley, P. M. (1997) Virology 232, 260-268[CrossRef][Medline] [Order article via Infotrieve] |
9. | Huber, M., Cattaneo, R., Spielhofer, P., Orvell, C., Norrby, E., Messerli, M., Perriard, J. C., and Billeter, M. A. (1991) Virology 185, 299-308[Medline] [Order article via Infotrieve] |
10. | Curran, J., Marq, J. B., and Kolakofsky, D. (1995) J. Virol. 69, 849-855[Abstract] |
11. | Horikami, S. M., Curran, J., Kolakofsky, D., and Moyer, S. A. (1992) J. Virol. 66, 4901-4908[Abstract] |
12. | Ryan, K. W., and Portner, A. (1990) Virology 174, 515-521[Medline] [Order article via Infotrieve] |
13. | Buchholz, C. J., Retzler, C., Homann, H. E., and Neubert, W. J. (1994) Virology 204, 770-776[CrossRef][Medline] [Order article via Infotrieve] |
14. | Curran, J. (1996) Virology 221, 130-140[CrossRef][Medline] [Order article via Infotrieve] |
15. |
Curran, J.
(1998)
J. Virol.
72,
4274-4280 |
16. | Curran, J., Homann, H., Buchholz, C., Rochat, S., Neubert, W., and Kolakofsky, D. (1993) J. Virol. 67, 4358-4364[Abstract] |
17. | Buchholz, C. J., Spehner, D., Drillien, R., Neubert, W. J., and Homann, H. E. (1993) J. Virol. 67, 5803-5812[Abstract] |
18. | Liston, P., Batal, R., DiFlumeri, C., and Briedis, D. J. (1997) Arch. Virol. 142, 305-321[CrossRef][Medline] [Order article via Infotrieve] |
19. | Myers, T. M., Smallwood, S., and Moyer, S. A. (1999) J. Gen. Virol. 80, 1383-1391[Abstract] |
20. | Bankamp, B., Horikami, S. M., Thompson, P. D., Huber, M., Billeter, M., and Moyer, S. A. (1996) Virology 216, 272-277[CrossRef][Medline] [Order article via Infotrieve] |
21. | Myers, T. M., Pieters, A., and Moyer, S. A. (1997) Virology 229, 322-335[CrossRef][Medline] [Order article via Infotrieve] |
22. | Heggeness, M. H., Scheid, A., and Choppin, P. W. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 2631-2635[Abstract] |
23. | Heggeness, M. H., Scheid, A., and Choppin, P. W. (1981) Virology 114, 555-562[Medline] [Order article via Infotrieve] |
24. | Ryan, K. W., Portner, A., and Murti, K. G. (1993) Virology 193, 376-384[CrossRef][Medline] [Order article via Infotrieve] |
25. |
Zhang, X.,
Glendening, C.,
Linke, H.,
Parks, C. L.,
Brooks, C.,
Udem, S. A.,
and Oglesbee, M.
(2002)
J. Virol.
76,
8737-8746 |
26. | Harty, R. N., and Palese, P. (1995) J. Gen. Virol. 76, 2863-2867[Abstract] |
27. |
Coronel, E. C.,
Takimoto, T.,
Murti, K. G.,
Varich, N.,
and Portner, A.
(2001)
J. Virol.
75,
1117-1123 |
28. | Deshpande, K. L., and Portner, A. (1984) Virology 139, 32-42[Medline] [Order article via Infotrieve] |
29. | Hubbard, S. J., and Beynon, R. J. (2001) in Proteolytic Enzymes (Beynon, R. J. , and Bond, J. D., eds), 2nd Ed. , pp. 233-264, Oxford University Press, Oxford, UK |
30. | Tompa, P. (2002) Trends Biochem. Sci. 27, 527-533[CrossRef][Medline] [Order article via Infotrieve] |
31. |
Uversky, V. N.
(2002)
Protein Sci.
11,
739-756 |
32. | Dunker, A. K., Lawson, J. D., Brown, C. J., Williams, R. M., Romero, P., Oh, J. S., Oldfield, C. J., Campen, A. M., Ratliff, C. M., Hipps, K. W., Ausio, J., Nissen, M. S., Reeves, R., Kang, C., Kissinger, C. R., Bailey, R. W., Griswold, M. D., Chiu, W., Garner, E. C., and Obradovic, Z. (2001) J. Mol. Graph. Model. 19, 26-59[CrossRef][Medline] [Order article via Infotrieve] |
33. | Dunker, A. K., and Obradovic, Z. (2001) Nat. Biotechnol. 19, 805-806[CrossRef][Medline] [Order article via Infotrieve] |
34. | Dunker, A. K., Garner, E., Guilliot, S., Romero, P., Albrecht, K., Hart, J., Obradovic, Z., Kissinger, C., and Villafranca, J. E. (1998) Pac. Symp. Biocomput. 3, 473-484 |
35. | Wright, P. E., and Dyson, H. J. (1999) J. Mol. Biol. 293, 321-331[CrossRef][Medline] [Order article via Infotrieve] |
36. |
Uversky, V. N.
(2002)
Eur. J. Biochem.
269,
2-12 |
37. | Dyson, H. J., and Wright, P. E. (2002) Curr. Opin. Struct. Biol. 12, 54-60[CrossRef][Medline] [Order article via Infotrieve] |
38. | Buckland, R., Giraudon, P., and Wild, F. (1989) J. Gen. Virol. 70, 435-441[Abstract] |
39. | Giraudon, P., Jacquier, M. F., and Wild, T. F. (1988) Virus Res. 10, 137-152[CrossRef][Medline] [Order article via Infotrieve] |
40. | Pothier, P., and Bour, J. B. (1997) Med. Malad. Infect. 11, 592-597 |
41. | Karlin, D., Longhi, S., Receveur, V., and Canard, B. (2002) Virology 296, 251-262[CrossRef][Medline] [Order article via Infotrieve] |
42. | Brizzard, B. L., Chubet, R. G., and Vizard, D. L. (1994) BioTechniques 16, 730-735[Medline] [Order article via Infotrieve] |
43. | Brinkmann, U., Mattes, R. E., and Buckel, P. (1989) Gene (Amst.) 85, 109-114[CrossRef][Medline] [Order article via Infotrieve] |
44. | Uversky, V. N. (1993) Biochemistry 32, 13288-13298[Medline] [Order article via Infotrieve] |
45. | Piotto, M., Saudek, V., and Sklenar, V. (1992) J. Biomol. NMR 2, 661-665[Medline] [Order article via Infotrieve] |
46. | Morris, M. C., Mery, J., Heitz, A., Heitz, F., and Divita, G. (1999) J. Pept. Sci. 5, 263-271[CrossRef][Medline] [Order article via Infotrieve] |
47. | Narayanan, T., Diat, O., and Boesecke, P. (2001) Nucl. Instr. Methods Phys. Res. A 467, 1005-1009 |
48. | Guinier, A., and Fournet, F. (1955) Small Angle Scattering of X-rays , Wiley Interscience, New York |
49. | Svergun, D. (1992) J. Appl. Crystallogr. 25, 495-503[CrossRef] |
50. | Bergmann, A., Fritz, G., and Glatter, O. (2000) J. Appl. Crystallogr. 33, 1212-1216[CrossRef] |
51. | Frank, J., Radermacher, M., Penczek, P., Zhu, J., Li, Y., Ladjadj, M., and Leith, A. (1996) J. Struct. Biol. 116, 190-199[CrossRef][Medline] [Order article via Infotrieve] |
52. | Cuff, J. A., Clamp, M. E., Siddiqui, A. S., Finlay, M., and Barton, G. J. (1998) Bioinformatics 14, 892-893[Abstract] |
53. | Brown, C. J., Takayama, S., Campen, A. M., Vise, P., Marshall, T. W., Oldfield, C. J., Williams, C. J., and Keith Dunker, A. (2002) J. Mol. Evol. 55, 104-110[CrossRef][Medline] [Order article via Infotrieve] |
54. | Li, X., Romero, P., Rani, M., Dunker, A. K., and Obradovic, Z. (1999) Genome Inform. Ser. Workshop Genome Inform. 10, 30-40[Medline] [Order article via Infotrieve] |
55. | Uversky, V. N., Gillespie, J. R., and Fink, A. L. (2000) Proteins 41, 415-427[CrossRef][Medline] [Order article via Infotrieve] |
56. | Liu, J., Tan, H., and Rost, B. (2002) J. Mol. Biol. 322, 53-64[CrossRef][Medline] [Order article via Infotrieve] |
57. | Wilkins, D. K., Grimshaw, S. B., Receveur, V., Dobson, C. M., Jones, J. A., and Smith, L. J. (1999) Biochemistry 38, 16424-16431[CrossRef][Medline] [Order article via Infotrieve] |
58. | Hua, Q. X., Jia, W. H., Bullock, B. P., Habener, J. F., and Weiss, M. A. (1998) Biochemistry 37, 5858-5866[CrossRef][Medline] [Order article via Infotrieve] |
59. | Van Hoy, M., Leuther, K. K., Kodadek, T., and Johnston, S. A. (1993) Cell 72, 587-594[Medline] [Order article via Infotrieve] |
60. | Receveur, V., Durand, D., Desmadril, M., and Calmettes, P. (1998) FEBS Lett. 426, 57-61[CrossRef][Medline] [Order article via Infotrieve] |
61. | Russo, D., Durand, D., Calmettes, P., and Desmadril, M. (2001) Biochemistry 40, 3958-3966[CrossRef][Medline] [Order article via Infotrieve] |
62. | Panick, G., Malessa, R., Winter, R., Rapp, G., Frye, K. J., and Royer, C. A. (1998) J. Mol. Biol. 275, 389-402[CrossRef][Medline] [Order article via Infotrieve] |
63. | Perez, J., Vachette, P., Russo, D., Desmadril, M., and Durand, D. (2001) J. Mol. Biol. 308, 721-743[CrossRef][Medline] [Order article via Infotrieve] |
64. |
Konno, T.,
Kamatari, Y. O.,
Kataoka, M.,
and Akasaka, K.
(1997)
Protein Sci.
6,
2242-2249 |
65. | Glatter, O., and Kratzy, O. (1982) Small Angle X-ray Scattering , Academic Press, London |
66. | Finch, J. T., and Gibbs, A. J. (1970) J. Gen. Virol. 6, 141-150[Medline] [Order article via Infotrieve] |
67. |
Schoehn, G.,
Iseni, F.,
Mavrakis, M.,
Blondel, D.,
and Ruigrok, R. W.
(2001)
J. Virol.
75,
490-498 |
68. | Liston, P., DiFlumeri, C., and Briedis, D. J. (1995) Virus Res. 38, 241-259[CrossRef][Medline] [Order article via Infotrieve] |
69. | Tarbouriech, N., Curran, J., Ebel, C., Ruigrok, R. W., and Burmeister, W. P. (2000) Virology 266, 99-109[CrossRef][Medline] [Order article via Infotrieve] |
70. | Tarbouriech, N., Curran, J., Ruigrok, R. W., and Burmeister, W. P. (2000) Nat. Struct. Biol. 7, 777-781[CrossRef][Medline] [Order article via Infotrieve] |
71. | Marion, D., Tarbouriech, N., Ruigrok, R. W., Burmeister, W. P., and Blanchard, L. (2001) J. Biomol. NMR 21, 75-76[CrossRef][Medline] [Order article via Infotrieve] |
72. | Diamond, R. (1974) J. Mol. Biol. 82, 371-391[Medline] [Order article via Infotrieve] |
73. |
Dedmon, M. M.,
Patel, C. N.,
Young, G. B.,
and Pielak, G. J.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
12681-12684 |
74. | Daughdrill, G. W., Hanely, L. J., and Dahlquist, F. W. (1998) Biochemistry 37, 1076-1082[CrossRef][Medline] [Order article via Infotrieve] |
75. | Gast, K., Damaschun, H., Misselwitz, R., Muller-Frohne, M., Zirwer, D., and Damaschun, G. (1994) Eur. Biophys. J. 23, 297-305[CrossRef][Medline] [Order article via Infotrieve] |
76. | De, B. P., and Banerjee, A. K. (1999) Microsc. Res. Tech. 47, 114-123[CrossRef][Medline] [Order article via Infotrieve] |
77. | Moyer, S. A., Baker, S. C., and Horikami, S. M. (1990) J. Gen. Virol. 71, 775-783[Abstract] |
78. | Egelman, E. H., Wu, S. S., Amrein, M., Portner, A., and Murti, G. (1989) J. Virol. 63, 2233-2243[Medline] [Order article via Infotrieve] |
79. | Curran, J., Pelet, T., and Kolakofsky, D. (1994) Virology 202, 875-884[CrossRef][Medline] [Order article via Infotrieve] |
80. | Curran, J., Boeck, R., Lin-Marq, N., Lupas, A., and Kolakofsky, D. (1995) Virology 214, 139-149[CrossRef][Medline] [Order article via Infotrieve] |
81. |
ten Oever, B. R.,
Servant, M. J.,
Grandvaux, N.,
Lin, R.,
and Hiscott, J.
(2002)
J. Virol.
76,
3659-3669 |
82. | Marie, J. C., Kehren, J., Trescol-Biemont, M. C., Evlashev, A., Valentin, H., Walzer, T., Tedone, R., Loveland, B., Nicolas, J. F., Rabourdin-Combe, C., and Horvat, B. (2001) Immunity 14, 69-79[CrossRef][Medline] [Order article via Infotrieve] |
83. |
Ravanel, K.,
Castelle, C.,
Defrance, T.,
Wild, T. F.,
Charron, D.,
Lotteau, V.,
and Rabourdin-Combe, C.
(1997)
J. Exp. Med.
186,
269-278 |